Porosome
- Biotech or pharma, therapeutic R&D
Porosome Therapeutics Unveils Groundbreaking Discovery in Alzheimer’s Disease Research and Treatment – Associated Press
Porosome Therapeutics, Inc. announced its latest development in identifying the secretory dysfunction responsible for Alzheimer’s Disease along with advancements in therapeutic neuronal nanomachines. These innovations may transform the future of AD research and treatment. The company’s new findings suggest that combining porosome restoration with small molecule and peptide therapy may not only slow the progression of Alzheimer’s but also potentially reverse early-stage pathology, moving beyond the traditional focus on amyloid accumulation.
“For the first time in over a century since Alzheimer’s disease was identified, we have achieved a molecular-level understanding of how this condition impairs neurosecretion and disrupts communication within the brain,” said Bhanu P. Jena, founder and a distinguished cell biologist known for his discovery of the porosome nanomachine.
Address
BostonMassachusetts
United States
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}